Ethics

Vaccines

Volumn , Issue , 2008, Pages 1677-1683

  Caplan, Arthur L ^a,b   Schwartz, Jason L ^c  

^a Department of Medical Ethics ^*  (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

^c UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 80053357031     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-1-4160-3611-1.50080-5     Document Type: Chapter

References (57)

1. Polio infections in four unvaccinated children–Minnesota, August–October 2005. MMWR 54 1-3.
2. L Serpell and J Green (2006) Parental decision-making in childhood vaccination. Vaccine 24 4041-4046.
3. TC Davis, DD Fredrickson, CL Arnold, et al. (2001) Childhood vaccine risk/benefit communication in private practice office settings: a national survey. Pediatrics 107 17-28.
4. C Grady (2004) Ethics of vaccines research. Nat Immunol 5 465-468.
5. RE Spier (2004) Ethical aspects of the methods used to evaluate the safety of vaccines. Vaccine 22 2085-2090.
6. HT Shapiro and EM Meslin (2001) Ethical issues in the design and conduct of clinical trials in developing countries. N Eng J Med 345 139-141.
7. H Varmus and D Satcher (1997) Ethical complexities of conducting research in developing countries. N Eng J Med 337 1003-1005.
8. M Angell (1997) The ethics of clinical research in the third world. N Eng J Med 337 847-849.
9. BR Bloom (1999) Ethical issues in AIDS vaccine development. AIDS Patient Care STDS 13 273-280.
10. Ethical considerations in HIV preventive vaccine research UNAIDS guidance document. 2000. Retrieved March 24, 2006 from. http://data.unaids.org/Publications/IRC-pub01/JC072-EthicalCons_en.pdf
11. R Bayer (2000) Ethical challenges of HIV vaccine trials in less developed nations: conflict and consensus in the international arena. AIDS 14 1051-1057.
12. D Guenter, J Esparza and R Macklin (2000) Ethical considerations in international HIV vaccine trials: summary of a consultative process conducted by the Joint United Nations Programme on HIV/AIDS (UNAIDS). J Med Ethics 26 37-43.
13. S Berkley (2003) Thorny issues in the ethics of AIDS vaccine trials. Lancet 362 992.
14. Scientific considerations for the regulation and clinical evaluation of HIV/AIDS preventive vaccines. AIDS 16 W15–W25.
15. BR Bloom (1998) The highest attainable standard: ethical issues in AIDS vaccines. Science 279 186-188.
16. R Macklin (2006) Changing the presumption: providing ART to vaccine research participants. Am J Bioeth 6 W1-W5.
17. Specter M. The vaccine: has the race to save Africa from AIDS put Western science at odds with Western ethics? New Yorker, February 3, 2003, 54–65.
18. JD Smith and AL Mitchell (2001) Sacrifices for the miracle: the polio vaccine research and children with mental retardation. Ment Retard 39 405-409.
19. NW Baylor and K Midthun (2004) Regulation and testing of vaccines. SA Plotkin, WA Orenstein (Eds) Vaccines 4th ed Philadelphia: Saunders
20. SS Ellenberg, MA Foulkes, K Midthun and KL Goldenthal (2005) Evaluating the safety of new vaccines: summary of a workshop. Am J Public Health 95 800-807.
21. DA Gust, TW Strine, M Maurice, et al. (2004) Underimmunization among children: effects of vaccine safety concerns on immunization status. Pediatrics 114 16-22.
22. RE Spier (2004) Ethical aspects of the methods used to evaluate the safety of vaccines. Vaccine 22 2085-2090.
23. Ethics rules for advisory committee members and other individuals appointed as special government employees (SGEs). U.S. Department of Health and Human Services. Retrieved March 30, 2006 from. http://ethics.od.nih.gov/Topics/SGE-Training-Oct-04.pdf
24. MJ Goodman and J Nordin (2006) Vaccine adverse event reporting source: a possible source of bias in longitudinal studies. Pediatrics 117 387-390.
25. D Ridgway (1999) No-fault vaccine insurance: lessons from the National Vaccine Injury Compensation Program. J Health Polit Policy Law 24 59-90.
26. AL Caplan (2005) Boom and bust: have we learned what we need to from the flu vaccine shortage? Advanced Studies in Medicine 5 522-523.
27. P Danzon and NS Pereira (2005) Why sole-Supplier vaccines markets may be here to stay. Health Aff 24 694-696.
28. MS Coleman, N Sangrujee, F Zhou and S Chu (2005) Factors affecting U.S. manufacturers’ decisions to produce vaccines. Health Aff 24 635-642.
29. JO Klein and MG Myers (2006) Strengthening the Supply of routinely administered vaccines in the United States: problems and proposed solutions. Clin Infect Dis 42(Suppl 3), S97-S103.
30. LE Rodewald, WA Orenstein, DD Mason and SL Cochi (2006) Vaccine Supply problems: a perspective of the Centers for Disease Control and Prevention. Clin Infect Dis 42(Suppl 3), S104-S110.
31. SH Jacobson, EC Sewell, RA Proano and JA Jokela (2006) Stockpile levels for pediatric vaccines how much is enough? Vaccine 24 3530-3537.
32. R Giffin, K Stratton and R Chalk (2004) Childhood vaccine finance and safety issues. Health Aff 23 98-111.
33. KA Lees, PM Wortley and SS Coughlin (2005) Comparison of racial/ethnic disparities in adult immunization and cancer screening. Am J Prev Med 29 404-411.
34. WA Orenstein, LE Rodewald and AR Hinman (2004) Immunization in the United States. SA Plotkin, WA Orenstein (Eds) Vaccines 4th ed Philadelphia: Saunders
35. AR Hinman, BG Gellin and the National Vaccine Advisory Committee Institute of Medicine report on Financing Vaccines in the 21st Century: National Vaccine Advisory Committee/National Vaccine Program Office follow-up. 2004. Retrieved July 6, 2006 from. www.hhs.gov/nvpo/nvac/NVAC-IOM100604.htm
36. TK McInerny, WL Cull and BK Yudkowsky (2005) Physician reimbursement levels and adherence to American Academy of Pediatrics well-visit and immunization recommendations. Pediatrics 115 833-838.
37. ‘Merck to create new patient assistance program for vaccines’ 2006. Retrieved July 3, 2006 from. www.merck.com/newsroom/press_releases/corporate/2006_0526.html
38. DM Salisbury and JJ Olive (2004) Immunization in Europe. SA Plotkin, WA Orenstein (Eds) Vaccines 4th ed Philadelphia: Saunders
39. SC Hadler, SL Cochi, J Bilous and FT Cutts (2004) Vaccination programs in developing countries. SA Plotkin, WA Orenstein (Eds) Vaccines 4th ed Philadelphia: Saunders
40. WA Orenstein and AR Hinman (1999) The immunization system in the United States-the role of school immunization laws. Vaccine 17 S19-S24.
41. JS Rota, DA Salmon, LE Rodewald, et al. (2001) Processes for obtaining nonmedical exemptions to state immunization laws. Am J Public Health 91 645-648.
42. DA Salmon, LH Moulton, SB Omer, et al. (2004) Knowledge, attitudes, and beliefs of school nurses and personnel and associations with nonmedical immunization exemptions. Pediatrics 113 552-559.
43. J Guyon (October 31, 2005) The coming storm over a cancer vaccine. Fortune 152 123-130.
44. JC Abma, GM Martinez, WD Mosher and BS Dawson (2004) Teenagers in the United States: Sexual activity, contraceptive use, and childbearing, 2002. National Center for Health Statistics. Vital Health Stat 23 24.
45. RM Mays, LA Sturm and GD Zimet (2004) Parental perspectives on vaccinating children against sexually transmitted infections. Soc Sci Med 58 1405-1413.
46. N Munoz, FX Bosch, X Castellsague, et al. (2004) Against which human papillomavirus types shall we vaccinate and screen? The international perspective. Int J Cancer 111 278-285.
47. A Batson (2005) The problems and promise of vaccine markets in developing countries. Health Aff 24 690-693.
48. JK Andrus and J Fitzsimmons (2005) Introduction of new and underutilized vaccines: sustaining access, disease control, and infrastructure development. PLoS Med 2 e286.
49. MT Osterholm (2005) Preparing for the next pandemic. N Eng J Med 352 1839-1842.
50. EJ Emanuel and A Wertheimer (2006) Who should get influenza vaccine when not all can? Science 312 854-855.
51. JD Arras (2006) Ethical issues in the distribution of influenza vaccines. Yale J Biol Med forthcoming
52. B Schwartz and B Gellin (2005) Vaccination strategies for an influenza pandemic. J Infect Dis 191 1207-1209.
53. KV Iserson and N Pesik (2003) Ethical resource distribution after biological, chemical, or radiological terrorism. Camb Q Healthc Ethics 12 455-465.
54. LO Gostin (2002) Public health law in an age of terrorism: rethinking individual rights and common goods. Health Aff 21 79-93.
55. GJ Annas (2002) Bioterrorism, public health, and civil liberties. N Eng J Med 346 1337-1342.
56. C Feudtner and EK Marcuse (2001) Ethics and immunization policy: promoting dialogue to sustain consensus. Pediatrics 107 1158-1164.
57. R Macklin and B Greenwood (2003) Ethics and vaccines. BR Bloom, P Lambert (Eds) The Vaccine Book Amsterdam: Academic Press